surmount-1 tirzepatide non-diabetic obesity trial without diabetes on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial tirzepatide obesity without – SURMOUNT-1 Study Finds Individuals with

Over a year, that is $120 to $360 wasted

Marathe SJ et al

Interestingly, colonic L-cells possess twice as much total GLP-1 compared to L-cells from the upper GI tract (53)

Suppresses appetite and reduces cravings Slows digestion so you feel full longer Improves metabolic function Often greater total weight loss than single-pathway options How the program works Start with a complimentary consultation

HSA and FSA accounts cover all PlexusDx medications, making therapy accessible regardless of your insurance status

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) and remains flatyour dose may need to go up, but your price won't